Purchase Order HHSP284201600268A
Award Date
9/19/16
Potential Completion Date
10/19/16
Potential Value
$206K
Federal Agency
Office of the Assistant Secretary for Administration
Awardee
Pd-Rx Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oklahoma City, OK 73127, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The $1,682,440.00 contract is for the procurement of various sterile injectable drugs, antibiotics, anesthetics, and other pharmaceutical products. The contract has an ultimate completion date of September 30, 2015 and was not designated as a set-aside. Based on...
This is a $1,067,516.00 firm-fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The contract is for the provision of sterile injectable drugs, solutions, and other medical products to the CDC. This award is not a set-aside and is part of a larger contract vehicle between Hospira and the government. Based on the contract details,...
This federal contract award, valued at $24,538,976.00, was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Baxter Healthcare Corporation, doing business as Baxter Health Systems, for the procurement of pharmaceuticals. The contract is a definitive, firm-fixed price contract with an ultimate completion date of September 30, 2015. Baxter Healthcare Corporation, a manufacturer of medical devices, pharmaceuticals, and biotechnology products, serves as...
This federal contract award, SPE2DX15D5017|HHSN269201500468U, was issued by the Office of the Chief Operating Officer, a civilian agency, to the prime contractor Amerisourcebergen Drug Corp. The $94,263.54 Firm Fixed Price delivery order contract is for the provision of a broad range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines across multiple therapeutic areas. The...
This is a federal contract award to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The award is a delivery order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a ceiling value of $19,362,816.00 and a firm fixed price pricing type. The contract is for the provision of injectable pharmaceutical products, including antibiotics, critical care medications, and anesthesia...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, a delivery order valued at $10,062,096.00, is for the provision of injectable drugs, intravenous solutions, and other pharmaceutical products. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, reflecting Fresenius Kabi USA, LLC's status as a large, foreign-owned business...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a 5-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The $15,329,706.00 contract is for the delivery of various sterile injectable drugs, antibiotics, anesthetics, and other medical solutions to the agency. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation....
This federal contract award, with ID SPE2DX15D5017|HHSN269201600356U, was issued by the Department of Health and Human Services (HHS) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,074.00 firm fixed-price delivery order is not associated with a set-aside designation, indicating open competition. The contract encompasses the provision of a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award is for the delivery of COVID-19 vaccine mRNA (Pfizer) to the U.S. government. The contract, valued at $151,436.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This is a firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the provision of injectable pharmaceutical products under the SAGENT TASK ORDER 0001. The contract has a ceiling value of $200,985.60 and an ultimate completion date of September 27, 2016. Sagent Pharmaceuticals is a for-profit organization and a registered federal contractor, supplying critical medical supplies...